Search
Protocol No.: S2302
- Title
- PRAGMATICA - LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
- Principal Investigator
- Almubarak, Mohammed
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Lung Cancer
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Carla Ross, RN
- Senior Research Nurse
- Phone: +1 304-293-2633
- Email: carla.ross@hsc.wvu.edu
- Maher Kali, MD
- Clinical Research Specialist
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org
- Nnennaya Opara
- Clinical Research Specialist
- Phone: +1 681-342-1000
- Email: nnennaya.opara1@wvumedicine.org